Mendel AI
Founded Year
2016Stage
Series B | AliveTotal Raised
$60.2MLast Raised
$40M | 1 yr agoAbout Mendel AI
Mendel.ai provides clinical trial-matching solutions. It uses artificial intelligence (AI) to help providers and institutions implement evidence-based treatment, including referrals to clinical trials. Mendel AI was founded in 2016 and is based in San Jose, California.
Compete with Mendel AI?
Ensure that your company and products are accurately represented on our platform.
Mendel AI's Products & Differentiators
Retina
Optical Character Recognition technology
Research containing Mendel AI
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Mendel AI in 5 CB Insights research briefs, most recently on Dec 21, 2022.
Expert Collections containing Mendel AI
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Mendel AI is included in 8 Expert Collections, including Clinical Trials Tech.
Clinical Trials Tech
341 items
Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.
Artificial Intelligence
10,624 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Digital Health
10,012 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma companies and and assistive tech developers.
Clinical Trials Tech Market Map
108 items
This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.
Biopharma Tech
326 items
Latest Mendel AI News
Jul 19, 2022
Sailu Challapalli named as Chief Product Officer and Hylton Kalvaria named as Chief Commercial Officer July 19, 2022 09:00 AM Eastern Daylight Time SAN JOSE, Calif.--( BUSINESS WIRE )-- Mendel , the leading clinical artificial intelligence and natural language processing platform, today announced the expansion of its leadership team with two key C-suite hires: Sailu Challapalli as Chief Product Officer and Hylton Kalvaria as Chief Commercial Officer. The company continues to source exceptional individuals from the strongest organizations in healthcare and technology. Challapalli and Kalvaria bring significant experience to the Mendel team to aid the company’s strategic expansion. “We’re excited to welcome Sailu and Hylton to Mendel’s executive leadership team,” said Karim Galil, co-founder and CEO of Mendel. “Sailu and Hylton hail from some of the most important and disruptive real world evidence companies in the world. I’m thrilled to have them lead and grow our product, customer and commercial organizations.” Challapalli has nearly two decades of experience working in healthcare consulting, academic medical centers, and healthcare technology companies. Most recently, she served as the VP of Product Management at Flatiron Health, where she helped to scale its custom real world evidence data & analytic product line. Prior to Flatiron, Challapalli held various roles at Kyruus, in McKinsey & Company’s Healthcare Systems & Services practice, and at Columbia University Medical Center focused on leveraging healthcare technologies and data to improve patient access and quality of care. Kalvaria joins Mendel from Verana Health where he served as Chief Business Officer. At Verana, he built a world class commercial and delivery function including sales, marketing, partnerships and quantitative science teams. Kalvaria previously held a variety of roles at Flatiron Health and Genentech, both focused on the development and usage of high quality real world evidence for use across the healthcare industry. The healthcare industry faces immense challenges in parsing unstructured medical data that is highly valuable, but also extremely difficult and expensive to access. Mendel's solution unlocks 80% of the world's clinical data by leveraging contextual understanding to transform unstructured electronic medical record (EMR) data and clinical literature into comprehensive and compliant analytics-ready data. It abstracts data 27,000 times faster than the primarily manual methods most frequently used in clinical settings, and its output is reviewed and validated by a team of clinical experts to guarantee research-grade output. Mendel closed a $40 million Series B funding round in April from Oak HC/FT with participation from existing investor DCM. The company is poised for significant market expansion in 2022 and will be expanding headcount across offices in San Francisco Bay Area, New York City and Cairo, Egypt. For more information about Mendel visit Mendel.ai, and to see open positions visit Mendel.ai/careers . About Mendel Mendel is a machine that can read and understand medicine. Mendel Health is a for-profit corporation headquartered in San Jose, California, that uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to unlock a wide range of Real World Data applications. For more information about Mendel, visit Mendel.ai . Contacts
Mendel AI Frequently Asked Questions (FAQ)
When was Mendel AI founded?
Mendel AI was founded in 2016.
Where is Mendel AI's headquarters?
Mendel AI's headquarters is located at 111 West St John Street, San Jose.
What is Mendel AI's latest funding round?
Mendel AI's latest funding round is Series B.
How much did Mendel AI raise?
Mendel AI raised a total of $60.2M.
Who are the investors of Mendel AI?
Investors of Mendel AI include DCM Ventures, Oak HC/FT Partners, SOSV, BootstrapLabs, LaunchCapital and 10 more.
Who are Mendel AI's competitors?
Competitors of Mendel AI include Autonomize, COTA, Dyania Health, Vasta Global, ConcertAI and 7 more.
What products does Mendel AI offer?
Mendel AI's products include Retina and 4 more.
Compare Mendel AI to Competitors
Deep 6 AI provides clinical treatments to patients. It uses artificial intelligence and natural language processing on clinical data to find eligible patients for clinical trials. Its software accelerates patient recruitment and getting life-saving treatment to patients. It was formerly known as Deep 6 Analytics. It was founded in 2016 and is based in Pasadena, California.
Syapse develops software for aggregating and structuring biomedical data. It combines data intelligence, insight analytics and applied experience through healthcare organizations looking to transform patients’ lives using real-world evidence. The company was founded in 2008 and is based in San Francisco, California.
Evidation operates as a multichannel health tracking platform. It enables users to connect with multiple appications to track everyday activity and earn rewards for steps, sleep, surveys, and more. The company was founded in 2012 and is based in San Mateo, California.
ScienceIO develops a biomedical information platform to accelerate therapeutic and clinical workflows. The company is developing a platform to facilitate modern drug discovery, development, and patient care.
Aetion is a healthcare analytics company delivering real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. The company was founded in 2013 and is based in New York, New York.
Sycamore Informatics offers a way for clinical trial data handling, analysis and reporting functions to be more efficient and cost-saving. It is based in Waltham, Massachusetts.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.